Genmab reported DKK443M in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agios Pharmaceuticals AGIO:US $ 1.01M 0.44M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 32782M 97M
AstraZeneca AZN:LN 27495M 7363M
Bayer BAYN:GR € 40372M 2493M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Exelixis EXEL:US $ 0M 0M
Fresenius Medical Care FME:GR € 13116M 216M
Galapagos GLPG:NA € 27.91M 0.74M
Genmab GEN:DC DK 443M 65M
GlaxoSmithKline GSK:LN 25483M 736M
GN Store Nord GN:DC DK 6123M 109M
GRIFOLS GRF:SM € 7933.89M 565.82M
H. Lundbeck A/S LUN:DC 5.79B 444M
Hikma Pharmaceutical HIK:LN 932M 0
Immunogen IMGN:US $ 1.1M 1M
Insmed INSM:US $ 564.02M 186.91M
Lonza Group LONN:SW 3.65B 67M
Merck MRK:GR € 11999M 349M
Novartis NOVN:VX SF 35769M 2030M
Regeneron Pharmaceuticals REGN:US $ 2697.6M 0.9M
Seattle Genetics SGEN:US $ 0M 0M
William Demant Holding WDH:DC 10.74B 1.73B